Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Study of EGCG for the Prevention and Treatment of Peripheral Neuropathy Induced by Taxane (TIPN)

NCT06524609 is registered in ClinicalTrials.gov with Han Xi Zhao as lead sponsor.

NCT NCT06524609
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06524609 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Study of EGCG for the Prevention and Treatment of Peripheral Neuropathy Induced by Taxane (TIPN)
Lead sponsor
Han Xi Zhao
Phase
Phase 1/2
Overall status
Unknown status
Start date
November 30, 2023
Completion date
January 30, 2025
Enrollment
36 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chemotherapy-induced peripheral neuropathy